trial · primary record
Adagrasib
Carcinoma, Non-Small-Cell Lung
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 630 |
| Primary completion | 2032-04-30 |
| Primary endpoint | Progression Free Survival (PFS) as Assessed per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 by Blinded Independent Central Review (BICR) |
| Registry ID | NCT06875310 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:52.263Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06875310
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.